138 related articles for article (PubMed ID: 32819238)
21. Chronic urticaria and the metabolic syndrome: a cross-sectional community-based study of 11 261 patients.
Shalom G; Magen E; Babaev M; Tiosano S; Vardy DA; Linder D; Horev A; Saadia A; Comaneshter D; Agmon-Levin N; Cohen AD
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):276-281. PubMed ID: 28846167
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome among individuals with heroin use disorders on methadone therapy: Prevalence, characteristics, and related factors.
Vallecillo G; Robles MJ; Torrens M; Samos P; Roquer A; Martires PK; Sanvisens A; Muga R; Pedro-Botet J
Subst Abus; 2018 Jan; 39(1):46-51. PubMed ID: 28771091
[TBL] [Abstract][Full Text] [Related]
23. [Carbohydrate metabolic disorders in gout: incidence and clinical features].
Eliseev MS; Barskova VG
Ter Arkh; 2010; 82(5):50-4. PubMed ID: 20597271
[TBL] [Abstract][Full Text] [Related]
24. Validity of gout diagnosis in Swedish primary and secondary care - a validation study.
Dehlin M; Stasinopoulou K; Jacobsson L
BMC Musculoskelet Disord; 2015 Jun; 16():149. PubMed ID: 26077041
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.
Pinhas-Hamiel O; Livne M; Harari G; Achiron A
Eur J Neurol; 2015 Sep; 22(9):1275-9. PubMed ID: 25973530
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome in primary gout.
González-Senac NM; Bailén R; Torres RJ; de Miguel E; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):185-91. PubMed ID: 24940668
[TBL] [Abstract][Full Text] [Related]
27. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of the metabolic syndrome in kidney transplant recipients: A single-center study.
Hami M; Sabbagh MG; Sefidgaran A; Mojahedi MJ
Saudi J Kidney Dis Transpl; 2017; 28(2):362-367. PubMed ID: 28352021
[TBL] [Abstract][Full Text] [Related]
29. INCREASED RISK OF COLORECTAL CANCER IN PATIENTS WITH CHRONIC TOPHACEOUS GOUT: A POPULATION-BASED STUDY.
Boustany A; Rahhal R; Mitri J; Onwuzo S; Zeid HKA; Asaad I
Arq Gastroenterol; 2023; 60(3):339-344. PubMed ID: 37792763
[TBL] [Abstract][Full Text] [Related]
30. Validation of gout diagnosis in electronic primary care medical records: A population-based study.
Pou MA; Martinez-Laguna D; Estebanez JL; Aivar M; Gayarre R; Conesa A; Hoyo J; Carbonell C; Reyes C; Diaz-Torne C
Joint Bone Spine; 2023 Dec; 90(6):105628. PubMed ID: 37634875
[TBL] [Abstract][Full Text] [Related]
31. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
33. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
34. [Characteristics and clinical significance of body composition in gout patients].
Deng C; Li QH; Yang LJ; Liang JJ; Mo YQ; Lin JZ; Zheng DH; Dai L
Zhonghua Nei Ke Za Zhi; 2019 Oct; 58(10):751-757. PubMed ID: 31594173
[No Abstract] [Full Text] [Related]
35. Metabolic syndrome characteristics in gout patients.
Fraile JM; Torres RJ; de Miguel ME; Martínez P; Lundelin KJ; Vázquez JJ; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):325-9. PubMed ID: 20544515
[TBL] [Abstract][Full Text] [Related]
36. Clinical and epidemiological aspects of gout, a dysmetabolic disabling disorder.
Macovei LA; Brujbu IC
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):62-8. PubMed ID: 25970944
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of metabolic syndrome in a Portuguese obese adolescent population according to three different definitions.
Braga-Tavares H; Fonseca H
Eur J Pediatr; 2010 Aug; 169(8):935-40. PubMed ID: 20177702
[TBL] [Abstract][Full Text] [Related]
38. Changes in Urinary Microalbumin Levels after Correction of Hyperuricemia in Patients with Gout: An Observational Cohort Study.
Vaidya B; Pudasaini K; Nakarmi S
Int J Rheumatol; 2020; 2020():8310685. PubMed ID: 32308689
[TBL] [Abstract][Full Text] [Related]
39. Female gout. Clinical spectrum and uric acid metabolism.
Puig JG; Michán AD; Jiménez ML; Pérez de Ayala C; Mateos FA; Capitán CF; de Miguel E; Gijón JB
Arch Intern Med; 1991 Apr; 151(4):726-32. PubMed ID: 2012455
[TBL] [Abstract][Full Text] [Related]
40. The six obesity indices, which one is more compatible with metabolic syndrome? A population based study.
Motamed N; Sohrabi M; Poustchi H; Maadi M; Malek M; Keyvani H; Amoli MS; Zamani F
Diabetes Metab Syndr; 2017; 11(3):173-177. PubMed ID: 27658893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
